第1章 目錄

第2章 簡介

第3章 競爭產品的評估

第4章 開發中產品的評估

概要

各開發階段的開發平台

開發中產品簡介

乳癌的搭配診斷檢驗

大腸癌症的搭配診斷檢驗

黑色素瘤的搭配診斷檢驗

非小細胞肺癌的搭配診斷檢驗

第5章 現在、未來市場參與企業

企業策略的趨勢

搭配診斷的經營模式

企業簡介

開發搭配診斷檢驗法的製藥/治療企業

開發搭配診斷檢驗法(和製藥企業共同)的診斷企業

第6章 附錄

圖表一覽

目錄

Product Code: GDME1026FPR

A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy. This report provides an analysis of the companion diagnostic market for four major cancers in the US, the 5EU (France, Germany, Italy, Spain, and UK), Brazil, and the some of the Asia-Pacific (APAC) regions (Japan, China, and India), and identifies the unmet needs in this companion diagnostics market. This report analyses companion diagnostic tests used in breast, colorectal, melanoma and non-small cell lung cancer. This report also discusses physician attitudes towards current companion diagnostic tests, and the future of companion diagnostic tests. This report focuses on the major test kits that are supplied to pathology laboratories.

The report identifies and analyzes the key companies shaping and driving the Companion Diagnostic market. The report provides insight into the competitive Companion Diagnostic landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading doctors, with in-house analysis conducted by GlobalData's team of industry experts.

Scope

Investigation of current and future market competition for Companion Diagnostic

Competitor assessment including device approval analysis.

Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.

Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Companion Diagnostic in clinical practice.

Reasons to buy

Gain a high level view of the trends shaping and driving the Companion Diagnostic market.

Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.